Small bowel lymphoma in unrecognized coeliac disease: a cause for concern?
1Department of Medicine, Royal Victoria Hospital, Belfast, Northern Ireland, UK. sjohnston@potblack.thegap.com
Background And Aim:
It is not clear whether the increased risk of small bowel lymphoma seen in typical coeliac disease also applies to unrecognized or screening-detected coeliac patients. The aim of the present study was to determine the features of small bowel lymphoma and whether it is associated with unrecognized coeliac disease at the time of presentation.
Design:
A retrospective search by the five pathology laboratories serving Northern Ireland, UK.
Methods:
Snomed searches were used to identify cases of adenocarcinoma (SBA) and lymphoma (SBL) affecting the small intestine between 1987 and 1996. Pathology reports were obtained and analysed with respect to the clinical features, site of pathology, type of tumour, grading and the presence or absence of distant villous atrophy.
Results:
One hundred and thirty-eight cases were identified of whom 69 (44 men; mean age 60.2 years) were SBL and 69 (41 men; mean age 68.0 years) were SBA. Comparing the SBL to the SBA group the clinical presentation was perforation (10 vs 1, P= 0.009), small intestinal obstruction (20 vs 20, P= 1.0) and small intestinal mass (13 vs 15, P= 0.67). B-cell lymphomas occurred in 20 cases, T-cell lymphomas in 24 cases and 25 were unclassified. There was one known coeliac patient in the SBL group and none in the SBA group (P = 1.0). Villous atrophy at a distant site was recorded in 13 patients in the SBL group compared to none in the SBA group, all of these patients having T-cell lymphomas.
Conclusions:
Similar numbers of SBL and SBA occurred in the study period. Their clinical presentation was similar although perforation was more common in the SBL group. One-third of all SBL patients (over half of T-cell lymphomas) had distant villous atrophy, indicating that small bowel lymphoma appears to be significantly associated with unrecognized coeliac disease.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease IV: Clinical Manifestations